Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.05 -0.04 (-0.33%)

Delayed Quote Updated: 11:17 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗

May 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 04, 2022

Via Benzinga

Recap: Amarin Corp Q1 Earnings ↗

May 04, 2022

Amarin Corp (NASDAQ:AMRN) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Amarin Corp's Earnings: A Preview ↗

May 03, 2022

Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

NASDAQ:AMRN Long Term Investor Notice: Investigation of Potential Wrongdoing at Amarin Corporation Plc ↗

March 09, 2022

San Diego, CA -- (SBWIRE) -- 03/09/2022 -- An investigation was announced for investors in shares of Amarin Corporation plc (NASDAQ:AMRN) concerning potential breaches of fiduciary duties by certain...

Via SBWire

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

Lower Vascepa Volume Hits Amarin's Q4 Topline Growth ↗

March 01, 2022

Amarin Corp plc's (NASDAQ: AMRN) Q4 FY21 sales decreased 13.6% Y/Y to $144.49 million, beating the consensus of $141.75 million. The decline was driven primarily by...

Via Benzinga

Amarin: Q4 Earnings Insights ↗

March 01, 2022

Amarin Corp (NASDAQ:AMRN) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

28 Stocks Moving In Tuesday's Mid-Day Session ↗

January 25, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,...

Via Benzinga

51 Biggest Movers From Yesterday ↗

January 26, 2022

Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗

January 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 25, 2022

Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

NASDAQ: AMRN Investor Notice: Deadline on December 23, 2021in Lawsuit Against Amarin Corporation Plc ↗

December 16, 2021

San Diego, CA -- (SBWIRE) -- 12/16/2021 -- A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc (NASDAQ: AMRN).

Via SBWire

Why Amarin Stock Tumbled in November ↗

December 07, 2021

The biopharma's stock could be near a bottom after last month's double-digit decline.

Via The Motley Fool

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

December 04, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Intellectual Property Lawsuit

LAWSUITS FILED AGAINST AMRN, CEI and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

November 22, 2021

NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, AMRN and FB

November 19, 2021

NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...

From The Gross Law Firm

Via AccessWire

Topics Intellectual Property Lawsuit

CLASS ACTION UPDATE for BMRN, AMRN and Z: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

November 19, 2021

NEW YORK, NY / ACCESSWIRE / November 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Intellectual Property Lawsuit

Lawsuits Filed Against AMRN, RECAF and HMLP - Jakubowitz Law Pursues Shareholders Claims

November 18, 2021

NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX

November 18, 2021

NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

CLASS ACTION UPDATE for INNV, ZEV and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

November 18, 2021

NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Intellectual Property Lawsuit

SHAREHOLDER ALERT: AMRN CEI SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

November 17, 2021

NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud Intellectual Property

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMRN, HMLP and ONTF

November 17, 2021

NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded...

From The Gross Law Firm

Via AccessWire

Topics Initial Public Offering Intellectual Property Lawsuit

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and CEI

November 16, 2021

NEW YORK, NY / ACCESSWIRE / November 16, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

Why Amarin Stock Crushed the Market on Tuesday ↗

November 16, 2021

An activist investor revealed that it held a small stake in the company.

Via The Motley Fool

Amarin Posts Encouraging Vascepa Data In Patients With Peripheral Artery Disease ↗

November 16, 2021

Amarin Corporation plc (NASDAQ: AMRN) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The...

Via Benzinga

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.